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Abstract
Background: Human exposure to Libby amphibole (LA) asbestos increases risk of lung cancer, mesothelioma, and
non-malignant respiratory disease. This study evaluated potency and time-course effects of LA and positive control
amosite (AM) asbestos fibers in male F344 rats following nose-only inhalation exposure.
Methods: Rats were exposed to air, LA (0.5, 3.5, or 25.0 mg/m3 targets), or AM (3.5 mg/m3 target) for 10 days and
assessed for markers of lung inflammation, injury, and cell proliferation. Short-term results guided concentration
levels for a stop-exposure study in which rats were exposed to air, LA (1.0, 3.3, or 10.0 mg/m3), or AM (3.3 mg/m3)
6 h/day, 5 days/week for 13 weeks, and assessed 1 day, 1, 3, and 18 months post-exposure. Fibers were relatively
short; for 10 mg/m3 LA, mean length of all structures was 3.7 μm and 1 % were longer than 20 μm.
Results: Ten days exposure to 25.0 mg/m3 LA resulted in significantly increased lung inflammation, fibrosis,
bronchiolar epithelial cell proliferation and hyperplasia, and inflammatory cytokine gene expression compared to
air. Exposure to 3.5 mg/m3 LA resulted in modestly higher markers of acute lung injury and inflammation
compared to AM. Following 13 weeks exposure, lung fiber burdens correlated with exposure mass concentrations,
declining gradually over 18 months. LA (3.3 and 10.0 mg/m3) and AM produced significantly higher bronchoalveolar
lavage markers of inflammation and lung tissue cytokines, Akt, and MAPK/ERK pathway components compared to air
control from 1 day to 3 months post-exposure. Histopathology showed alveolar inflammation and interstitial fibrosis in
all fiber-exposed groups up to 18 months post-exposure. Positive dose trends for incidence of alveolar epithelial
hyperplasia and bronchiolar/alveolar adenoma or carcinoma were observed among LA groups.
Conclusions: Inhalation of relatively short LA fibers produced inflammatory, fibrogenic, and tumorigenic effects in rats
which replicate essential attributes of asbestos-related disease in exposed humans. Fiber burden, inflammation, and
activation of growth factor pathways may persist and contribute to lung tumorigenesis long after initial LA exposure.
Fiber burden data are being used to develop a dosimetry model for LA fibers, which may provide insights on mode of
action for hazard assessment.
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Background
The vermiculite mine near Libby, in northwestern Mon-
tana was the world’s leading source of vermiculite for
70 years until its closure in 1990 [1]. Vermiculite is used
for insulation, as an absorbent material, and as a soil
conditioner, with applications in the construction, agri-
cultural, horticultural, and industrial markets. The Libby
vermiculite ore coexists with a complex array of amphi-
bole mineral types referred to as Libby amphibole (LA)
asbestos, primarily winchite, richterite, and tremolite,
which have a range of crystal morphologies ranging from
asbestiform to acicular or prismatic [2]. Occupational
exposure to LA is associated with significantly increased
risk of respiratory disease, including non-malignant re-
spiratory disease (such as localized and diffuse pleural
thickening, asbestosis, and autoimmune disease), lung
cancer, and mesothelioma, compared to background
rates within the U.S. population [3–11]. Risks of non-
occupational exposure to LA have also been reported.
For example, pleural abnormalities (calcifications, thick-
enings, or plaques) were identified on chest radiographs
in 18 % of 6668 persons who lived or worked in the
Libby area for at least 6 months before 1991, with
greater prevalence among those with more types or
routes of exposure [12, 13]. Outside of Libby, exposure
to LA is a continuing risk since the contaminated ver-
miculite ore was shipped to locations around the nation
for processing and used in a variety of applications, es-
pecially attic insulation which may be present in homes
throughout the United States [1].
Several previous studies have investigated the fibrotic
and tumorigenic effects of amphibole asbestos in rodents
[14, 15], although no inhalation studies have specifically
assessed the potency of LA asbestos present at the Libby
vermiculite mine. The goals of this study were to exam-
ine internal dose, time course of pathological effects,
and potential mode of action (MOA) of inhaled LA in
rats, and to improve the scientific basis for the risk as-
sessment of asbestos-contaminated communities. Inhal-
ation exposure scenarios were adapted from testing
strategies recommended for toxicity assessment of fi-
brous particles [16]. Effects of LA and amosite (AM), a
known fibrogenic and carcinogenic amphibole asbestos
fiber [14], were initially evaluated in rats exposed for
10 days in a nose-only inhalation study. This short-term
study provided data on early fiber effects and guided ex-
posure concentrations for a subsequent long-term stop-
exposure study in which rats were exposed by inhalation
to LA or AM for 13 weeks and then evaluated at differ-
ent time points up to 18 months post-exposure. The
biological potency of inhaled LA and AM over the near-
life span of the rat was compared in terms of lung in-
flammation and respiratory tract pathology, including
tumor formation. Since inflammation is thought to be a
key event leading to respiratory tract fibrosis and
tumorigenesis [17, 18], several markers and pathways of
inflammation were examined in lung tissue, including
mRNA expression of inflammasome pathway compo-
nents and pro-inflammatory cytokines, protein levels
of pro-inflammatory or pro-allergic cytokines, and
protein levels of Akt and mitogen-activated protein
kinases/extracellular signal-regulated kinases (MAPK/
ERK) pathway components. Additional fiber burden
data from the satellite component for time-course
data in this study are being used to develop a dosim-
etry model of amphibole fiber deposition, clearance,
and retention in the respiratory tract, pleura, and
lymph nodes. The dosimetry model will enable calcu-
lation of different dose metrics and translation of
dose across different exposure scenarios for linkage of
laboratory animal data to epidemiological data.
Results
Short-term inhalation study
Airway inflammation was assessed immediately after the
final day of nose-only inhalation exposure for 10 days
(5 days/week for 2 weeks; 6 h/day) to air alone or target
concentrations of 3.5 mg/m3 AM or 0.5, 3.5, or 25.0 mg/
m3 LA. Numbers of bronchoalveolar lavage fluid (BALF)
alveolar macrophages were not significantly affected by
exposure, whereas neutrophils were observed in all AM
and LA exposure groups, and were significantly higher
in the 25.0 mg/m3 LA-exposed group compared to all
other groups (Fig. 1). As a percentage of total BALF
cells, neutrophils were significantly higher in the 3.5
(10 %) and 25.0 (47 %) mg/m3 LA groups but not the
3.5 mg/m3 AM group (7 %) compared to air controls.
Lymphocytes were less than 1 % of total BALF cells in
all groups (not shown). Compared with all other groups,
the 25.0 mg/m3 LA group also had significantly greater
levels of BALF supernatant protein (marker of lung
edema and epithelial cell injury), lactate dehydrogenase
(LDH; marker of cytotoxicity), N-acetyl β-D glucosami-
nidase (NAG; marker of macrophage lysosomal activa-
tion), and alkaline phosphatase (ALP; marker of fibrosis
[19]) (Fig. 1). Protein and LDH levels were also signifi-
cantly higher in the 3.5 mg/m3 LA-exposed group
compared with air-, 0.5 mg/m3 LA-, and 3.5 mg/m3 AM-
exposed groups, indicating greater lung toxicity of LA
compared with AM at the same mass concentration.
Components of the NLRP3 inflammasome pathway,
including NALP3 (NACHT, LRR and PYD domains-
containing protein 3), encoded by the Nlrp3 (NOD-like
receptor family, pyrin domain containing 3) gene,
PYCARD (pyrin domain caspase recruitment domain
(CARD); also known as apoptosis-associated speck-like
protein containing a CARD (ASC)), and caspase-1
(Casp1), were initially recognized to play a role in
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inflammation and apoptosis in response to microbial in-
fection [20], and may contribute to the development of
fibrosis after asbestos exposure [21, 22]. Caspases in turn
can activate pro-inflammatory cytokines including
interleukin-1β (IL-1β) and IL-18 [20]. However, immedi-
ately after 10 days exposure to AM or LA, lung tissue
mRNA expression of Nlrp3, Pycard, and Casp1 were un-
changed in comparison to air-exposed controls (Fig. 2).
Expression of Il1b and Il18 were only modestly higher in
the 25.0 mg/m3 LA group. In contrast, expression of
several other pro-inflammatory cytokines, including Il6,
Tnfa (tumor necrosis factor-α; TNF-α), and Cxcl2 (che-
mokine (C-X-C motif ) ligand 2, also known as macro-
phage inflammatory protein 2) were 2- to 4-fold higher
in groups exposed to LA at 3.5 or 25.0 mg/m3, but were
not significantly higher in the AM group compared to
controls (Fig. 2). Expression of Ifng (interferon-γ; IFN-γ),
which has been shown to inhibit activation of the
NALP3 inflammasome [23], was unchanged in all groups
(not shown).
Lung histopathology was assessed 4 days after the 10-
day exposure (Table 1). Alveolar inflammation was ob-
served in all AM- and LA-exposed groups. The severity
of this change was greater in the 3.5 and 25.0 mg/m3 LA
groups compared to the AM group, similar to BALF
injury markers (LDH and protein) (Fig. 1). Alveolar
inflammation was characterized by infiltration of
macrophages and lesser numbers of neutrophils and
lymphocytes around alveoli, alveolar ducts, and terminal
bronchioles (TBs) (predominant centriacinar distribu-
tion) (compare Fig. 3a and b). Inflammation was often
associated with the presence of rod-shaped foreign bod-
ies (consistent with asbestos fibers) in the cytoplasm of
alveolar macrophages. In more severely affected areas,
cytotoxicity was evident and characterized by pyknotic
nuclei and karyorrhectic debris.
The incidences of bronchiolar epithelial hyperplasia
and interstitial fibrosis were also higher in the
25.0 mg/m3 LA group compared to the control air
group (Table 1). Bronchiolar hyperplasia was indicated
by an increased number of epithelial cells in the TBs
with variable degrees of karyomegaly and anisokaryo-
sis (Fig. 3c). Interstitial fibrosis was characterized by
fibroblasts and collagen deposition along alveolar
walls (most prominent at branch points into alveolar
sacs) and within areas of granulomatous inflamma-
tion. The increase in collagen was confirmed by
Fig. 1 Short-term inhalation study: lung inflammation markers in
bronchoalveolar lavage fluid (BALF) immediately after final exposure
to AM or LA for 10 days (5 days/week for 2 weeks; 6 h/day).
Numbers in legend represent target mass concentrations (mg/m3).
Values represent mean ± SE of BALF macrophages and neutrophils
(top panels) and concentrations of ALP, LDH, protein, and NAG in
BALF supernatant (middle and lower panels) (n = 7 rats/group). P < 0.05
† vs. all other groups; * vs. air control; # vs. LA 0.5; ‡ vs. AM 3.5
Fig. 2 Short-term inhalation study: transcriptional markers of
apoptosis and inflammation in lung samples after final exposure to
AM or LA for 10 days. Results show relative mean values ± SE of
lung tissue mRNA for inflammasome pathway components (Nlrp3,
Pycard, Casp1), downstream cytokines (Il1b and Il18), and other pro-
inflammatory cytokines (Il6, Tnfa, Cxcl2) as determined by RT-qPCR (n= 7
rats per group). P< 0.05 † vs. all other groups; * vs. air control; # vs. LA
0.5; ‡ vs. AM 3.5
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positive staining with Masson’s trichrome (not shown).
Occasional areas of fibrosis also contained foci of multila-
mellar mineralization.
Epithelial cell proliferation within TBs was assessed
by 5-bromo-2′-deoxyuridine (BrdU) labeling (compare
Fig. 3d and e). BrdU labeling index (LI) was increased
in a concentration-dependent manner in LA-exposed
rats (linear dose trend P = 0.001), and was signifi-
cantly greater for the 3.5 mg/m3 AM and 3.5 and
25.0 mg/m3 LA groups compared to the air control
group (adjusted P < 0.05 for all) (Fig. 3f ). Comparable
BrdU incorporation at the same mass concentration
of AM and LA contrasted with greater lung inflam-
mation for LA than AM (Fig. 1, Table 1). The latter
findings suggest that AM and LA exposure resulted
in a similar degree of terminal bronchiolar cytotox-
icity, which may occur independently from airway in-
flammation, at least in short-term exposures [24].
Table 1 Lung histopathology (left lobe) after exposure to AM or LA for 10 days
Air control AM LA LA LA
Target mass concentration (mg/m3) 0.00 3.50 0.50 3.50 25.00
Actual mass concentration (mg/m3) 0.08 ± 0.18 3.67 ± 1.58 0.53 ± 0.11 3.59 ± 0.91 26.76 ± 9.11
Foreign Bodya 0 6* 2 6* 7*
Alveolus Inflammationb 0 7 (1.0)* 6 (0.9)* 7 (2.0)* 7 (2.0)*
Focal Chronic Inflammationc 3 (0.4) 3 (0.4) 5 (0.7) 1 (0.1) 0
Bronchiole Epithelial Hyperplasia 0 0 0 0 5 (0.7)*
Interstitial Fibrosisd 0 4 (0.6) 0 3 (0.4) 7 (1.0)*
Rats were exposed to AM or LA 6 h/day, 5 days/week for 2 weeks and evaluated 4 days after final exposure. Mass concentration data shown are mean values ± SD
of daily mass concentrations. Other values represent the number of animals with a finding in each group (n = 7 per group). Average lesion severity scores for all
rats in each group (shown in parentheses) were graded as follows: 1 =minimal, 2 = mild, 3 = moderate, 4 = marked, and 5 = severe. *P < 0.05 vs. air control by
Fisher’s Exact Test. aConsistent with fibers; not graded for severity. bPredominantly macrophages with lesser numbers of neutrophils and lymphocytes, often
associated with foreign bodies. cSmall aggregates of alveolar macrophages, often subpleural; distinct from the predominantly centriacinar populations of mixed
inflammatory cells observed with “alveolus inflammation”. dConfirmed on Masson’s trichrome stain
Fig. 3 Short-term inhalation study: histopathologic effects and terminal bronchiolar epithelial cell proliferation 4 days after final exposure to AM
or LA for 10 days. a–c, Representative images of normal terminal bronchiole and surrounding alveoli from air control (Con) group (a), mixed
cell alveolar inflammation, predominantly macrophages and neutrophils (b), and bronchiolar epithelial hyperplasia (c). Slides were stained with
hematoxylin and eosin. d–f, Immunostaining of cells with BrdU. Representative images of terminal bronchioles from Con (d) and high concentration
LA (25 mg/m3 target) (e) groups. Positively labeled cells are indicated by brown nuclei; background staining used hematoxylin. f, Percentage of
positive BrdU-labeled cells (labeling index, LI), shown as individual LI values (circles), mean values (horizontal bars), and standard error (vertical bars) for
each group. *P < 0.05 and **P < 0.01 compared to air control (Con) group; ^ P < 0.01 by linear trend test among LA dose groups. Images were taken at
20x (a, c) or 40x (b, d, e) objective magnification
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Based on the overall inflammatory response in
BALF, expression of pro-inflammatory cytokines, and
histopathological effects in the lung, it was deter-
mined that the 13-week inhalation study should in-
corporate a 10-fold range of LA mass concentrations,
from 1.0 to 10.0 mg/m3 LA, and that the AM con-
centration of 3.3 mg/m3 should match the intermedi-
ate LA concentration.
13-week inhalation exposure characterization
Daily mass concentrations of the air control, AM
(3.3 mg/m3), and LA (1.0, 3.3, and 10.0 mg/m3) expo-
sures closely matched target levels in the 13-week inhal-
ation study (Table 2). Count median aerodynamic
diameters and geometric standard deviation (σg), as de-
termined weekly by an aerosol particle sizer (APS), were
similar for all asbestos exposures, averaging 0.9–1.1 μm
Table 2 Characteristics of 13-week subchronic exposure
Air control AM LA LA LA
Target mass concentration (mg/m3) 0.00 3.30 1.00 3.30 10.00
Actual mass concentration (mg/m3) 0.00 ± 0.16 3.32 ± 1.48 1.01 ± 0.45 3.34 ± 0.83 10.04 ± 2.04
APS: Count median aerodynamic diameter (μm) 1.41 ± 0.98 0.93 ± 0.04 1.05 ± 0.06 1.02 ± 0.03 1.13 ± 0.05
APS: σg 2.01 ± 0.58 1.40 ± 0.08 1.51 ± 0.03 1.46 ± 0.02 1.52 ± 0.04
APS: Particles/cc 1 ± 3 404 ± 132 43 ± 23 171 ± 56 280 ± 96
SEM: All structures/cc - 3101 ± 598 1158 ± 217 3728 ± 772 6718 ± 958
SEM: Total structures counted (n) - 3218 2557 4517 2674
SEM: All structure lengths, L (μm)
Mean - 1.9 ± 0.1 2.6 ± 0.4 3.3 ± 0.4 3.7 ± 0.4
Median 1.0 ± 0.1 1.4 ± 0.4 2.2 ± 0.4 2.5 ± 0.4
Maximum 21.0 ± 7.1 22.0 ± 6.0 25.3 ± 5.0 27.5 ± 8.4
SEM: All structure diameters, D (μm)
Mean - 0.33 ± 0.01 0.38 ± 0.03 0.43 ± 0.02 0.44 ± 0.03
Median 0.29 ± 0.01 0.32 ± 0.02 0.36 ± 0.02 0.37 ± 0.03
Maximum 1.38 ± 0.85 2.14 ± 0.78 2.29 ± 0.52 2.56 ± 1.29
SEM: All structure aspect ratios (L/D)
Mean - 5.8 ± 0.5 7.0 ± 0.9 8.7 ± 0.9 9.5 ± 0.8
Median 3.1 ± 0.3 3.8 ± 0.7 5.6 ± 0.9 6.2 ± 0.7
Maximum 60.7 ± 16.4 69.5 ± 36.6 86.8 ± 41.2 85.5 ± 42.4
SEM: WHO fibers/cc (L/D ≥3; L ≥5 μm) - 230 ± 56 159 ± 63 693 ± 199 1522 ± 304
SEM: Total WHO fibers counted (n) 237 349 838 601
Proportion of structures which are WHO fibers (%) - 7.4 13.6 18.6 22.5
SEM: WHO fiber L (μm)
Mean - 8.9 ± 0.9 9.0 ± 0.8 9.0 ± 0.6 9.3 ± 0.7
Median 7.3 ± 0.9 7.6 ± 0.7 7.6 ± 0.4 7.7 ± 0.6
SEM: WHO fiber D (μm)
Mean - 0.41 ± 0.04 0.51 ± 0.09 0.49 ± 0.03 0.52 ± 0.05
Median 0.37 ± 0.04 0.44 ± 0.08 0.42 ± 0.03 0.45 ± 0.04
Maximum 0.80 ± 0.25 1.46 ± 0.72 1.66 ± 0.48 1.47 ± 0.39
SEM: WHO fiber aspect ratios (L/D)
Mean - 24.8 ± 3.7 22.1 ± 2.8 22.5 ± 2.4 22.3 ± 2.1
Median 21.5 ± 3.9 18.6 ± 2.6 18.7 ± 1.6 17.7 ± 1.9
SEM: Fibers, L≥20 μm/cc (L/D≥3) - 7 ± 10 5 ± 6 26 ± 18 75 ± 52
Proportion of WHO fibers with L ≥20 μm (%) - 3.0 3.2 3.8 4.8
Results shown are mean values ± SD of all daily mass concentrations (n = 66–67 per group) and values from weekly aerodynamic particle sizer (APS) and scanning
electron microscopy (SEM) measurements (n = 12–14 per group)
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and 1.4–1.5, respectively. The APS indicated a higher
concentration of particles in the AM exposure compared
with the same mass concentration of LA, but examin-
ation of all asbestos structures (any dimension ≥ 0.2 μm)
with a scanning electron microscope (SEM) showed that
the number concentrations for the AM and LA 3.3 mg/
m3 exposures were comparable (3101/cm3 and 3728/cc,
respectively). Examination of all structure size distribu-
tions by SEM showed slightly greater lengths (L) and as-
pect ratios (L/diameter (D)) for the LA 3.3 mg/m3
exposure (mean L: 3.3 μm; L/D: 8.7) compared with the
AM exposure (mean L: 1.9 μm; L/D: 5.8). Lengths and
L/D of LA structures tended to increase at higher mass
concentrations (mean L: 3.7 μm; L/D: 9.5 at 10.0 mg/m3
LA). The greater L and L/D of LA compared to AM
structures resulted in a greater proportion of structures
classified as fibers as defined by the World Health
Organization (WHO) (L ≥ 5 μm and L/D ≥ 3): 7.4 % of
AM structures were WHO fibers compared with 18.6 %
of LA structures at the same mass concentration
(Table 2). Consequently, the AM exposure had only
44 % more WHO fibers/cc than the low LA exposure,
despite having 3-fold greater mass and structure concen-
tration. Within the WHO fiber class, L, D, and L/D were
similar for all AM and LA exposures. There were few
very long fibers (≥20 μm), which comprised 3–5 % of
WHO fibers (approximately 1 % or less of all structures),
and their concentration ranged up to 75 fibers/cc in
the 10.0 mg/m3 LA exposure. These LA and AM
fiber samples were overall relatively short in compari-
son to samples of AM or other asbestos types studied
previously [15, 25].
Tissue fiber burden
Development of a fiber dosimetry model will allow more
refined analysis of dose, density, dimensions and durabil-
ity of LA and AM, and exploration of alternative dose
metrics. A separate satellite component in this inhal-
ation study was aimed at characterizing fiber burdens in
various tissues (nasal cavity, trachea, lung lobes, lymph
nodes and pleura) after both acute and chronic expo-
sures to support development of a fiber dosimetry
model. The full design strategy for this satellite and asso-
ciated model development is the subject of other manu-
scripts. To provide context for the endpoints reported
herein, the numbers of all asbestos structures or WHO
fibers were determined in the lower respiratory tract
(LRT; i.e. five lung lobes) of asbestos-exposed groups at
each time point after the 13-week inhalation exposure
(Fig. 4). Lung asbestos structures and WHO fibers gen-
erally matched patterns of exposure aerosol mass, struc-
ture number, and WHO fiber concentrations (Table 2).
However, in contrast to the lower aerosol concentration
of AM WHO fibers relative to the 3.3 mg/m3 LA group,
AM lung WHO fibers were comparable to those in the
3.3 mg/m3 LA group at 1 day and 1 month post-
exposure. Asbestos structures and fibers declined slowly
post-exposure. By 3 and 18 months post-exposure, the
3.3 mg/m3 LA group, but not the AM group, had signifi-
cantly greater numbers of lung WHO fibers than the
1.0 mg/m3 LA group (Fig. 4). Numbers of lung asbestos
structures and WHO fibers were significantly greater in
the 10.0 mg/m3 LA target group than in all other groups
at all times post-exposure. The reduction of LA struc-
tures and fibers from the lung over time was generally
similar among the 3 LA exposure groups, indicating no
impaired clearance of LA fibers at the higher concentra-
tions of LA. Energy-dispersive X-ray spectroscopy (EDS)
analysis of lung fibers 18 months post-exposure con-
firmed the chemistry of the fibers was consistent with
LA or AM (Additional file 1: Figure S1). In comparison
with the lung, numbers of asbestos structures and WHO
fibers were far lower in the upper respiratory tract
(URT; i.e. nasal cavity), lung-associated mediastinal
lymph nodes, lung pleura, and trachea and larynx (data
not shown). Altogether, extra-pulmonary tissue asbestos
structures were typically less than 5 % of total (pulmon-
ary + extra-pulmonary) asbestos structures, while extra-
pulmonary WHO fibers were always less than 1.5 % of
total WHO fibers. Lymphatic clearance of smaller fibers
was evident from significantly increased total LA struc-
tures in the mediastinal lymph nodes at 1 and 18 months
Fig. 4 Long-term stop-exposure inhalation study: lung fiber burden.
Numbers of all asbestos structures (any structure with L ≥0.2 μm;
top panel) and WHO fibers (L≥5 μm, L/D≥3; bottom panel) recovered
in five lung lobes (LRT) of rats exposed to AM or LA for 13 weeks
(5 days/week for 13 weeks; 6 hr/day) and evaluated at 1 day, 1 month,
3 months, or 18 months after the end of the exposure. Values in
legend represent target mass concentrations (mg/m3). Results show
mean values ± SE (n= 4 rats per group). P< 0.05 † vs. all other groups; #
vs. LA 1.0 group
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post-exposure in the 10.0 mg/m3 LA group compared to
all other groups (data not shown). The 10.0 mg/m3 LA
group also had significantly increased total LA structures
in the pleura 1 day after exposure, suggesting greater
durability and a possible mechanism for pleural fibrosis
(see histopathology results below). Asbestos structures
and WHO fibers were sampled in three air control rats
3 months after exposure; 1 to 3 structures were found in
all fields from each control rat lung (≤0.2 × 104 calcu-
lated total in LRT) and no structures were detected in
any other tissues (data not shown).
Hematology and BALF inflammation
Thirteen weeks of exposure to AM or LA had few sig-
nificant effects on hematology parameters from 1 day to
18 months after exposure (Additional file 1: Table S1).
Compared to air-exposed controls, the percent of lym-
phocytes among WBCs was significantly reduced 1 day
after exposure to AM and 1.0 and 10.0 mg/m3 LA,
although the absolute number of lymphocytes was not
different. No difference from control was observed at
later time points. Platelets 1 month after 10.0 mg/m3
LA, hemoglobin (Hgb) 3 months after 3.3 mg/m3 LA,
and mean corpuscular volume (MCV) 3 months after
AM were reduced in comparison to air controls, but
overall there were no consistent changes in hematology
parameters after exposure to AM or LA.
Compared with air-exposed control groups, numbers
of BALF alveolar macrophages were unchanged at all
times after exposure to AM or LA (Fig. 5). However, as-
bestos exposure induces macrophages to become more
adherent to airways, likely reducing cell numbers in
BALF, whereas macrophage numbers are found to be
increased in alveolar duct bifurcations after asbestos ex-
posure [26]. Concentration-dependent increases in BALF
neutrophils were observed 1 day, 1 month, and 3 months
after AM or LA exposure. Neutrophil numbers were sig-
nificantly greater in the 10.0 mg/m3 LA group compared
with all other groups at these times. Neutrophils were
similar in AM and 3.3 mg/m3 LA groups and signifi-
cantly greater than air-exposed controls except for AM
at 3 months post-exposure. Lymphocyte numbers were
increased only in the 10.0 mg/m3 LA group 1 day after
exposure. BALF supernatant markers of epithelial injury,
cytotoxicity, and fibrosis (protein, LDH, and ALP, re-
spectively) were significantly increased from 1 day to
3 months after exposure to AM and higher concentra-
tions of LA (Fig. 5), although group differences were not
as marked as with BALF neutrophils. In contrast to re-
sults from the range-finding study, no clear differences
were observed between the AM and 3.3 mg/m3 LA
groups. By 18 months post-exposure the neutrophil and
lung injury responses had abated and there were no sig-
nificant differences among groups in BALF parameters.
Fig. 5 Long-term stop-exposure inhalation study: lung inflammation
markers in BALF. Rats were exposed for 13 weeks to AM or LA and
evaluated at 1 day, 1, 3, and 18 months post-exposure. Values in
legend represent target mass concentrations (mg/m3). Results show
means ± SE of BALF macrophages, neutrophils, and lymphocytes,
and concentrations of protein, LDH, and ALP (Alk Phos) in BALF
supernatant (n = 8 rats/group). P < 0.05 † vs. all other groups; * vs.
air control; # vs. LA 1.0; ‡ vs. AM 3.3; § vs. LA 3.3
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No differences in NAG activity levels were observed at
any time post-exposure (data not shown).
Inflammatory cytokines and Akt and MAPK/ERK pathways
Multiple cytokines and chemokines have been demon-
strated to play significant roles in particle and fiber-
induced pathologies [27, 28]. Chemokine (C-X-C motif )
ligand 1 (CXCL1; also known as keratinocyte chemo-
attractant/growth-related oncogene-alpha (KC/GRO-α))
is a functional homologue of IL-8 and a neutrophil
chemoattractant in rodents [29]. TNF-α is a pro-
inflammatory cytokine which induces fever, inflamma-
tion, and apoptosis [30]. IL-1β is a macrophage-derived
mediator of cell proliferation, differentiation, and apop-
tosis [31]. In lung tissue, all of these cytokines were in-
creased in a concentration-dependent manner by LA
from 1 to 3 months after the 13-week exposure (Fig. 6a).
Cytokine levels in the AM and 3.3 mg/m3 LA groups
were comparable. IFN-γ is produced by NK, NKT, and
Th1 cells and is critical for innate and adaptive immun-
ity [32]. Starting from a low air control value (~1 pg/
mg), IFN-γ was further reduced in the 10.0 mg/m3 LA
group compared to all other groups at 1 day, and
compared to air control and 1.0 mg/m3 LA at 3 months
after exposure. Although IL-13 contributes to pulmonary
fibrosis [33], lung tissue levels of pro-allergic cytokines
such as IL-4 and IL-13 were very low in all groups
(<0.5 pg/mg), and IL-5 did not have consistent time- or
concentration-dependent responses (data not shown).
The Akt (also known as protein kinase B) signaling
pathway regulates diverse cellular functions including
metabolism, growth, proliferation, cell survival, tran-
scription and protein synthesis [34]. In lung tissue, levels
of activated pAkt (phospho-Akt (Ser473)) were signifi-
cantly different from control levels in the AM and
3.3 mg/m3 and 10.0 mg/m3 LA groups only at 3 months
after exposure (Fig. 6b). In contrast, pS6RP (phospho-S6
ribosomal protein (Ser240/244)), activated downstream
of pAkt or by an alternative pathway [35], was elevated
in the 10.0 mg/m3 LA group at all times from 1 day to
3 months post-exposure. pS6RP was also elevated in the
3.3 mg/m3 AM group but not the corresponding
3.3 mg/m3 LA group at all time points. Levels of
p70S6K (phospho-70 kDa ribosomal protein S6 kinase
(Thr389)) and pGSK-3β (phospho-glycogen synthase
kinase-3β (Ser9)) were not different from control levels
A B
Fig. 6 Long-term stop-exposure inhalation study: lung pro-inflammatory cytokines and markers of Akt and ERK pathway activation from right
cranial lung lobe tissue. Rats were exposed for 13 weeks to AM or LA and evaluated at 1 day, 1, and 3 months after the end of the exposure.
Values in legend represent target mass concentrations (mg/m3). Results show mean values ± SE (n = 6–7 rats per group). a Cytokine levels
expressed relative to total protein in sample. b Phosphorylated components of Akt pathway (pAkt, pS6RP) and MAPK/ERK cascade (pMEK1/2,
pSTAT3) expressed relative to levels in air control group. P < 0.05 † vs. all other groups; * vs. air control; # vs. LA 1.0; ‡ vs. AM 3.3; § vs. LA 3.3
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at any time after exposure (data not shown). Compo-
nents of the MAPK/ERK pathway regulate functions in-
cluding proliferation, differentiation, and development of
malignancies [36, 37]. Levels of activated pMEK1/2
(phospho-mitogen-activated protein ERK kinase 1, 2
(Ser217/221)) were increased over control levels in the
10.0 mg/m3 LA group at 1 month and 3 months post-
exposure, and at 1 day after exposure in the 3.3 mg/m3
LA group (Fig. 6b). Levels of pERK1/2 (phospho-extra-
cellular signal-regulated kinase 1, 2 (Thr202/Thr204;
Thr185/Tyr187)), downstream from pMEK1/2 [37], were
not significantly different from control levels at any time
(data not shown). Levels of activated pSTAT3 (phospho-
signal transducer and activator of transcription 3
(Tyr705)), which may be activated by Janus kinases in a
separate pathway from MEK1/2 [38], were increased
over control levels in the AM and 3.3 mg/m3 and
10.0 mg/m3 LA groups only at 3 months after exposure.
Survival and histopathology
Rats which survived 18 months post-exposure were
100 weeks old at the scheduled necropsy. Exposure to
AM and varying concentrations of LA for 13 weeks did
not significantly affect early mortality before scheduled
necropsy, which ranged from 9 to 19 rats in each group
of 50 (18–38 %). Average lifespan was 97.7, 98.0, 96.4,
98.2, and 97.8 weeks for 18-month control, AM, and 1.0,
3.3, and 10.0 mg/m3 LA groups, respectively (P = 0.42)
(Additional file 1: Figure S2). The leading cause of mor-
tality among early deaths was mononuclear cell leukemia
(MCL), which is a common finding in older male Fischer
rats [39, 40] (Additional file 1: Table S2). No significant
group differences were observed for the incidence of
MCL or other findings in early death animals, and rates
were comparable to earlier studies [33].
Histopathological findings 1 day post-exposure in the
13-week study included foreign bodies (consistent with
fibers) within alveolar macrophages, alveolar inflamma-
tion, interstitial fibrosis, and bronchiolization in all fiber-
exposed groups and bronchiolar epithelial hyperplasia
only in the 10.0 mg/m3 LA group (Table 3). The abun-
dant alveolar macrophages are consistent with prior
studies showing these cells as the predominant inflam-
matory cell type in alveoli following asbestos exposure
[41]. Granulomas composed of macrophage aggregates
and rare giant cells were occasionally present, consistent
with a foreign body response. Similar findings were evi-
dent in all AM and LA groups 1 and 3 months post-
exposure, with the exception of bronchiolar epithelial
hyperplasia at the 3-month time point. At the 18-month
recovery period, scant fibers could still be identified
within macrophages and scattered multinucleated giant
cells in the majority of the animals from each fiber
group (Fig. 7a). Fibers did not accumulate to the degree
associated with overload of alveolar macrophages, indi-
cating that overload did not contribute to the observed
pathological changes. Other histopathological findings in
all fiber-exposed groups included alveolar inflammation
and interstitial, pleural, and subpleural fibrosis (Fig. 7b, c).
The AM and 10.0 mg/m3 LA groups also had a higher
incidence of alveolar epithelial hyperplasia (Fig. 7d)
which showed a positive dose trend among LA
groups (P = 0.0099).
Bronchiolar/alveolar (B/A) tumors (adenoma and car-
cinoma) were observed in 8 animals (2 each in the AM
and 3.3 mg/m3 LA groups (4 % incidence) and 4 in the
10.0 mg/m3 LA dose group (8 % incidence)) (Table 3).
Microscopically, B/A adenomas presented as discrete
masses composed of ribbons and sheets of cuboidal cells
that filled alveolar spaces and compressed adjacent tissue
(Fig. 7e). Neoplastic cells within adenomas were typically
monomorphic with low rates of mitotic activity. The one
carcinoma exhibited cytologic atypia, local and vascular
invasion (Fig. 7f ), and metastasis to the thoracic cavity,
diaphragm, kidney, ribs, sternum, and heart leading to
death. There was no significant pairwise difference in
the incidence of lung adenoma and/or carcinoma be-
tween groups (unadjusted P = 0.058 using time-adjusted
analysis). However, there was a statistically significant
trend in tumor incidence for combined pulmonary aden-
oma or carcinoma using a Cochran-Armitage Trend
Test (Exact Test) (P = 0.0064 for all 18-month animals
with pathology data; P = 0.0067 using time-adjusted ana-
lysis). No pleural mesotheliomas were observed in any of
the treatment groups.
In systemic tissues examined other than the lung,
there was greater incidence of minimal to mild chronic
tracheal inflammation only in the 10.0 mg/m3 LA group
(Table 3). This change was characterized by an infiltra-
tion of mononuclear cells in the tracheal submucosa.
Other spontaneous/background changes included hypos-
permia in the epididymal tubules and tubular atrophy,
edema, and interstitial cell adenomas in the testis
(Additional file 1: Table S3). The incidence and severity
of these findings in the fiber-exposed groups were simi-
lar to the air control group. All other histopathological
findings were considered incidental.
Discussion
This study was designed to evaluate internal dose, time
course dynamics of pathological effects, and potential target
pathways for inhaled LA relative to AM, a distinct amphi-
bole with established toxicity. Lung fiber burdens after
13-week exposures were concordant with aerosol mass,
asbestos structure number, and WHO fiber concentrations,
and were similar between matched concentrations of LA
and AM. Asbestos structure and fiber burdens declined
gradually post-exposure but approximately half the original
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Table 3 Lung and trachea histopathology after exposure to AM or LA for 13 weeks
Air control AM 3.3 LA 1.0 LA 3.3 LA 10.0
Lung
Foreign Bodya
1 Day 0 8* 8* 8* 8*
1 Month 0 8* 8* 8* 8*
3 Months 0 8* 8* 8* 8*
18 Months 0 47* 40* 48* 49*
Alveolus Inflammationb
1 Day 0 8 (1.0)* 8 (1.0)* 8 (1.0)* 8 (2.0)*
1 Month 0 8 (1.1)* 8 (1.0)* 8 (1.0)* 8 (2.0)*
3 Months 0 8 (1.0)* 8 (1.0)* 8 (1.1)* 8 (1.4)*
18 Months 0 45 (1.0)* 40 (0.9)* 47 (1.1)* 48 (1.1)*
Alveolar Epithelial
Hyperplasiac
1 Day 0 0 0 0 0
1 Month 0 0 0 0 1 (0.1)
3 Months 0 0 0 0 1 (0.1)
18 Months 1 (0.0) 9 (0.3)* 6 (0.2) 6 (0.2) 9 (0.4)*^
Bronchiole Epithelial
Hyperplasia
1 Day 0 0 0 0 8 (1.0)*
1 Month 0 1 (0.1) 0 0 8 (1.0)*
3 Months 0 0 0 0 0
18 Months 0 0 0 0 0
Bronchiolizationd
1 Day 0 8 (1.0)* 7 (0.9)* 8 (1.0)* 8 (1.0)*
1 Month 0 7 (0.9)* 7 (0.9)* 7 (0.9)* 8 (1.4)*
3 Months 0 8 (1.0)* 8 (1.0)* 8 (1.0)* 8 (1.0)*
18 Months 0 5 (0.1) 5 (0.1) 0 0
Interstitial Fibrosise
1 Day 0 8 (1.0)* 8 (1.0)* 8 (1.0)* 8 (1.0)*
1 Month 0 8 (1.0)* 7 (0.9)* 8 (1.0)* 8 (1.0)*
3 Months 0 8 (1.0)* 8 (1.0)* 8 (1.0)* 8 (1.0)*
18 Months 0 42 (0.8)* 29 (0.6)* 43 (0.9)* 42 (0.9)*
(Sub) Pleural Fibrosise
18 Months 0 25 (0.5)* 16 (0.3)* 19 (0.4)* 22 (0.4)*
Bronchiolar/Alveolar Adenoma
18 Months 0 2 0 2 3^
Bronchiolar/Alveolar Carcinoma
18 Months 0 0 0 0 1
Bronchiolar/Alveolar Adenoma
or Carcinoma
18 Months 0 2 0 2 4^
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lung burden was still present 18 months after exposure.
The biological potency of inhaled LA in the 13-week study
was comparable to that of AM on a mass basis. After
short-term exposures, some of the early inflammatory
responses such as LDH, protein, pro-inflammatory cytokine
expression, and alveolar inflammation were more severe for
LA compared to the same mass concentration of AM, but
following the 13-week study, early and persistent effects of
LA and AM were similar in terms of inflammation markers
and respiratory tract pathology. Several target pathways im-
plicated in tumorigenesis were observed after asbestos ex-
posure, including Akt, MAPK/ERK, and pro-inflammatory
cytokines. These findings clearly demonstrate persistence of
inflammatory and fibrotic responses to relatively short LA
fibers which may drive proliferative effects and contribute
to lung tumorigenesis long after primary exposure.
Several reviews and assessments have evaluated the risk
of respiratory tract cancer among vermiculite workers at
Libby [1, 3, 6, 11, 42]. These studies consistently reported a
higher overall risk of death due to lung or other respiratory
tract cancers, with mortality rates from 1.4 to 2.4 times
higher than control non-exposed populations. Exposure-
response analyses from these studies further showed a
positive relationship between lung cancer mortality and
exposure, using different measures of exposure, lag periods,
and exposure metrics, with ~2- to 3-fold greater risk in the
highest exposure group [1]. In this study a dose trend for
increased lung tumors was observed among the LA-
Table 3 Lung and trachea histopathology after exposure to AM or LA for 13 weeks (Continued)
Trachea
Trachea, Chronic Inflammation
18 Months 0 0 4 (0.1) 2 (0.1) 9 (0.2)*
Trachea, Squamous Metaplasia
18 Months 0 1 (0.0) 0 0 0
Rats were exposed to AM or LA for 13 weeks and evaluated at 1 day, 1 month, 3 months, or 18 months after the end of the exposure period. Column headings
indicated target mass concentrations (mg/m3). Values represent the number of animals with a finding in each group (total examined n = 8 at 1 day, 1, and
3 months, and n = 49–50 at 18 months). Average lesion severity scores for all rats in each group (shown in parentheses) were graded as follows: 1 =minimal, 2 =
mild, 3 = moderate, 4 = marked, and 5 = severe. *P < 0.05 vs. air control; ^P < 0.05 for trend test among LA groups. aConsistent with fibers; not graded for severity.
bPredominantly macrophages with lesser numbers of neutrophils and lymphocytes, often associated with foreign bodies; occasional granulomas with rare giant
cells. cProliferation of cuboidal type II alveolar cells (without evidence of significant inflammation). dPresence of cells that resemble bronchiolar epithelial cells in
alveolar ducts and adjacent alveoli. eConfirmed on Masson’s trichrome stain
Fig. 7 Stop-exposure inhalation study: persistent effects on histopathology 18 months after exposure to AM or LA for 13 weeks. All images
shown are from 10 mg/m3 LA target mass concentration except panel E (3.3 mg/m3 LA). Images represent a alveolar inflammation
(macrophages) with intracytoplasmic fibers (arrowheads), b interstitial fibrosis (indicated by blue-stained collagen), c subpleural fibrosis (lower
image) compared to normal pleura (upper image), d alveolar epithelial hyperplasia (indicated by cuboidal type II pneumocytes lining alveolar
walls), e bronchiolar/alveolar (B/A) adenoma, and f B/A carcinoma. Slides were stained with either hematoxylin and eosin (a, d–f) or Masson’s
trichrome (b, c). Images were taken at 60x (a), 40x (b, c), or 20x (d–f) objective magnification
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exposed groups. This effect is considered to be treatment-
related given the statistical significance (P < 0.01), the time-
and dose-concordance of related early effects (e.g. increased
cell proliferation, hyperplasia, inflammation), and sup-
porting data from human epidemiologic studies [1]. Lung
tumor incidence for AM and 3.3 mg/m3 LA groups
(4 %) was similar to historical control estimates previously
reported in aged male F344 rats. For example, at the
National Toxicology Program (NTP), the historical control
incidence of combined B/A tumors in aged male Fischer
344 rats is ~3.6 % [39]. However, historical control values
may vary by site/institution and sectioning protocol, so
direct comparisons should be treated with caution. Only
left lung was examined on histopathology here, resulting in
a lower sampling intensity compared to other protocols in
which both left and right lung lobes are examined [43].
The MOA for lung tumorigenicity in response to LA
has not been clearly established. Proposed key events in-
clude sustained local cytotoxicity and inflammation lead-
ing to increased cellular proliferation and hyperplasia
[1]. Findings from this study support this MOA, showing
that LA induces these events as direct effects which then
persist long after exposure has ended. Cytotoxicity was
indicated in the short-term study by increased LDH in
BALF and inflammation with pyknotic nuclei and kar-
yorrhectic debris in all fiber-exposed groups at all time
points on histopathology. Inflammation was also indi-
cated by BALF markers in higher-dose LA groups and
gene markers in mid- and high-dose LA groups. Bron-
chiolar epithelial cell proliferation was significantly
higher in the 3.3 and 10.0 mg/m3 LA groups and showed
a clear dose trend among LA groups. This finding was
supported by higher incidence of bronchiolar epithelial
hyperplasia following 10 days exposure (25 mg/m3 LA)
and 1 day and 1 month following 13 weeks of exposure
(10 mg/m3 LA), and alveolar epithelial hyperplasia at the
10 mg/m3 LA dose 18 months after the 13-week expos-
ure. Increased BrdU LI in TB epithelial cells was found
to be the best predictive measure of long-term patho-
genicity of fibers among several short-term in vitro and
in vivo endpoints [24]. Inflammation and histopathology
findings observed in this study were comparable to a
recent study in which male F344 rats were exposed to
LA or AM by intratracheal (IT) administration, with
fibers given in single or multiple bolus doses over a 13-
week period [44]. In that study, LA produced greater
acute inflammation and lung injury than AM, but long-
term histopathological changes were generally equiva-
lent, and similar to effects observed in the present study
with 10-day and 13-week exposures. Low numbers of B/
A adenomas, B/A carcinomas, and mesotheliomas were
found 20 months after IT exposure to AM or LA [44],
but with 24 animals per exposure group, no significant
dose trend could be detected.
This study found that in comparison to air control, in-
halation exposure of rats for 10 days to 3.5 mg/m3 AM
or LA up to 25 mg/m3 did not change mRNA expres-
sion of inflammasome pathway components, including
Nlrp3, Pycard, and Casp1, and only slightly increased
expression of genes for the downstream cytokines Il1b
and Il18. IL-1β production is typically mediated by
inflammasome-dependent caspase activation, although
other proteases can also process precursor IL-1β to its
active form (as demonstrated in studies of diesel exhaust
particulate exposure which induced pulmonary inflam-
mation and IL-1β in NLRP3 and caspase-1 knockout
mice [45]). Several studies utilizing high dose-rate ex-
posure techniques (IT, intranasal (IN), and in vitro) have
implicated the inflammasome pathway in the develop-
ment of asbestos- and particle-induced pathology. Lung
expression of Nlrp3 (Nalp3), Pycard (ASC), Il1b, and
Ctsb (cathepsin B, an activator of the inflammasome
pathway) were increased 4 h after IT instillation of rats
with 0.5 mg LA [46]. In comparison to wild-type mice,
lung inflammation and collagen deposition were signifi-
cantly reduced in knockout mice deficient in ASC or
Nalp3 3 months after IN instillation of 2 mg silica [21].
Finally, high asbestos and silica concentrations in vitro
stimulated macrophage IL-1β production, which was
dependent on the presence of inflammasome compo-
nents and reactive oxygen species production [22]. Al-
though inhalation exposure for 8 days to chrysotile
asbestos (7 mg/m3) was reported to produce lower BALF
inflammation and pro-inflammatory cytokines in Nlrp3
knockout mice compared to wild type mice, the effects
shown were marginal [22]. Together, these data suggest
that asbestos or silica exposure achieved through high
dose-rate bolus IT, IN, or in vitro exposures may activate
the inflammasome pathway, but more physiologically
relevant inhalation exposures to AM or LA as in the
present study do not stimulate this pathway to a signifi-
cant degree. Differences in the animal models used in
studies examining inflammasome activation may also
play a role in the variability of the response.
Chronic inflammation may play an important role in
the development of neoplasia [17, 18]. Although we did
not find evidence for activation of the inflammasome
pathway, other mediators of inflammation were elevated
after AM or LA exposure. Macrophages produce CXCL1
and CXCL2 which bind to C-X-C chemokine receptor 2
(CXCR2), induce neutrophil recruitment [47], and medi-
ate growth factor signaling networks that may contribute
to carcinogenesis [48]. Expression of Il6, Tnfa, and Cxcl2
were increased in a dose-dependent manner following
the 10-day exposure. TNF-α as well as CXCL2 are po-
tent neutrophil recruitment factors, which may contrib-
ute to the persistent neutrophilic response in the lung
up to 3 months following the 13-week exposure. As with
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measures of BALF protein and LDH, exposure to
3.5 mg/m3 LA, but not AM, significantly increased lung
tissue Tnfa and Cxcl2, suggesting that LA was more po-
tent than AM in producing an acute inflammatory re-
sponse leading to lung injury. Following the 13-week
exposure, lung tissue protein levels of CXCL1, TNF-α,
and IL-1β were increased in AM- and LA-exposed
groups. In contrast to the 10-day exposure, responses
following AM were comparable to those of LA at the
same exposure level, suggesting that persistent inflam-
matory responses to subchronic AM or LA exposure
were similar. Our results are consistent with previous
studies showing increases in expression of Cxcl1 and
Cxcl2 in lung tissue after IT exposure of rats to particles
or inhalation exposure of mice to crocidolite asbestos
[49]. These results suggest that cytokine-mediated neu-
trophil inflammation may have an important role in the
progression of lung injury and activation of growth fac-
tor pathways involved in tumor formation. Furthermore,
TNF-α also plays a critical role in asbestos-induced
interstitial fibrosis and cellular proliferation, as demon-
strated in TNF-α receptor knockout mice which had no
increase in BrdU labeling or fibrotic lesions after chryso-
tile exposure [50]. These effects of TNF-α may in turn
be mediated through activation of transforming growth
factor-β1 [51].
The Akt pathway is activated through membrane-bound
receptor tyrosine kinases and phosphatidylinositol 3-
kinase (PI3K), resulting in phosphorylation of Akt on
Ser473, among other sites [52]. pAkt promotes cell sur-
vival by inactivation of pro-apoptoptic proteins, including
GSK-3β by phosphorylation at Ser9 [34]. This study found
pAkt in lung tissue was elevated above control levels
3 months after the 13-week exposure to AM or LA, while
downstream pGSK-3β (Ser9) was unchanged from control
levels from 1 day to 3 months post-exposure, suggesting
that any inhibitory effects of AM or LA on apoptosis
occur by other pathways. Activated pS6RP, which has a
significant role in control of cell size and growth [35, 53],
may occur downstream from pAkt or separately
through activation by phosphoinositide-dependent
kinase 1 (PDK1) [35]. Further work is needed to define
the possible role of pS6RP in mediating effects of AM
and LA on bronchiolization and alveolar epithelial
hyperplasia. Active p70S6K (Thr389), one of the ki-
nases which phosphorylate S6RP [35, 53], was not ele-
vated above control levels at any time. Overall, these
results suggest a limited role for components of the
Akt pathway in events leading to tumor development
following exposure to AM or LA.
Previous studies have shown that the MAPK/ERK
pathway can play an important role in the development
of inflammation leading to tumor development after
asbestos, oxidant, or cigarette smoke exposure [54].
Increased levels of pMEK1/2 were found in lung tissue
after the 13-week exposure to higher concentrations of
LA, although levels of pERK1/2, downstream of
pMEK1/2 [37], were not consistently elevated. pSTAT3
may be activated downstream of pMEK1/2 or separately
by Janus kinases [37, 38], and elevated levels of pSTAT3
were found 3 months post-exposure to AM or LA. Since
this transcription factor promotes cell cycle progression,
cell transformation, and prevention of apoptosis [38],
elevation of pSTAT3 may also contribute to cell growth
signaling associated with tumor promotion.
The acute phase response is an essential component of
the innate immune system which is activated by infec-
tion, stress, and other stimuli [55]. Following IT dosing
of WKY or F344 rats with LA, several acute phase re-
sponse proteins were increased in serum, suggesting a
role for these markers in mediating the systemic inflam-
matory response to fibers [56]. The effects of AM or LA
delivered by inhalation or IT dosing on serum markers
were compared recently in samples from a comparative
toxicity study [57] and the present inhalation study [58].
One day after IT dosing of LA (0.5 or 1.5 mg/rat), the
acute phase marker α-2 macroglobulin was increased
more than 10-fold compared with 1 day after the 13-
week exposure to 10 mg/m3 LA, but no other acute
phase response or metabolic impairment markers were
increased after inhalation exposure. Other mediators of
inflammatory (and potential tumorigenic) responses to
LA include osteopontin and mesothelin [59, 60]. Serum
osteopontin was increased 1 day after IT LA in WKY
rats [56], and mesothelin was increased in lung tissue
2 years after IT LA in F344 rats [61]. Eighteen months
after the 13-week exposure to 10.0 mg/m3 LA in rats
from the present study, both osteopontin and mesothe-
lin were increased (though not significantly) in serum
[58]. These studies indicate that exposure to LA may ini-
tiate systemic immune and inflammatory responses
which interact with local effects in the lung.
The toxicity of asbestos or asbestiform minerals has
often been attributed to their fiber characteristics. Al-
though it is probable that shorter non-asbestiform (pris-
matic or acicular) fibers are less hazardous than longer
asbestiform fibers [62], all naturally occurring asbestos
samples contain a wide distribution of sizes, making it
critical to thoroughly analyze the physical characteristics
of the samples being tested. We found that LA WHO
fibers were more persistent in the lung than AM WHO
fibers, suggesting a greater potential for long-term tox-
icity with LA exposure. However, density and inhaled
size distribution influence aerodynamics and initial de-
position patterns, while the durability of fibers in vivo
influences clearance mechanisms. Caution in assigning
relative toxicity of fiber types is prudent until further
elucidation of the dose-response relevant to different
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endpoints can be more fully explored. Evaluation of add-
itional dose metrics such as fiber number or surface area
with various normalizing factors such as epithelial
surface area or number of alveolar macrophages may
provide additional useful insights on MOA. Dosimetry
models can predict various internal dose metrics to
inform the MOA for amphibole fibers, address interspe-
cies extrapolation, characterize uncertainty in exposure-
response models, and help to integrate evidence across
different experimental designs [63].
Conclusions
This study showed that inhalation of LA in rats pro-
duces inflammatory, fibrogenic, and tumorigenic effects
in the lung which include key features of asbestos-
associated disease in humans. Long-term effects were
produced by subchronic exposures to samples that
contained predominantly shorter fibers. Short-term ef-
fects included lung inflammation, terminal bronchiolar
epithelial cell proliferation, and pro-inflammatory cyto-
kine expression. Tissue fiber burdens persisted up to
18 months following subchronic inhalation, emphasizing
the important role of fiber dosimetry in determining
long-term (post-exposure) effects on the respiratory
tract. Markers of lung injury and pro-inflammatory cyto-
kines persisted up to 3 months post-exposure, while in-
flammatory and fibrotic changes on histopathology
persisted up to 18 months. Significant trends for alveolar
epithelial hyperplasia and B/A lung tumors were ob-
served 18 months after exposure among LA groups,
consistent with short-term effects on cell proliferation.
Examination of several inflammatory pathways involved
in tumorigenesis found no support for a role of the
inflammasome pathway, limited support for contribu-
tions of the Akt and MAPK/ERK pathways, and the
strongest support for the function of persistent pro-
inflammatory cytokines in mediating long-term LA
effects. Collectively, this evidence indicates that inflam-
mation and activation of growth factor pathways may
persist and contribute to lung tumorigenesis long after
initial LA exposure. These findings should contribute to
risk assessment of LA and the development of dosimetry
models of amphibole fibers.
Methods
Asbestos samples
Libby amphibole samples were collected from the Rainy
Creek Complex located near Libby, Montana, in 2007
and processed by the U.S. Geological Survey (Denver,
CO) into finer materials as described previously [64].
Union for International Cancer Control (UICC) AM was
used as a reference sample (CAS No. 12172-73-5).
Sample characteristics of LA and AM were previously
reported (Table 1 of [65] and associated online
Additional file 1).
Experimental design
A 2-week range-finding inhalation study was conducted
to guide exposure levels for the subsequent 13-week
inhalation study. Five groups of rats were exposed nose-
only 5 days/week for 6 h/day (10 days total) to high-
efficiency particulate air (HEPA)-filtered air only, LA
aerosol spanning a 50-fold range (0.5, 3.5, and 25.0 mg/
m3), or AM at 3.5 mg/m3. Rats were necropsied immedi-
ately after the final exposure for analyses of lung inflam-
mation and gene expression (n = 7/group), or 4 days
after final exposure for assessment of lung histopath-
ology and bronchiolar epithelial cell proliferation (n = 7/
group). For the 13-week inhalation study, five groups of
rats were exposed nose-only for 6 h/day 5 days/week to
HEPA-filtered air only, LA aerosol spanning a 10-fold
range (1.0, 3.3, and 10.0 mg/m3), or AM at 3.3 mg/m3.
Rats were necropsied 1 day, 1, 3, and 18 months after
the last exposure day (n = 8/group at 1 day, 1 month,
and 3 months post-exposure, and n = 50/group at
18 months post-exposure). Additional groups of rats
(n = 3–6/group) were exposed to determine fiber bur-
dens in the URT, trachea/larynx, LRT, pleura, and
mediastinal lymph nodes. For all time points, BALF
was collected from right lung lobes in eight animals/
dose group for cellular and lung injury endpoints,
and left lungs were collected for histopathology. At
1 day, 1, and 3 months post-exposure, right cranial
lung lobes were assessed for inflammatory cytokines
and proteins related to cell growth, proliferation, and
survival pathways. Animals in the 18-month post-
exposure arm were assessed for gross changes and
histopathology of left lung lobe, trachea, sternum,
pleura, testis, epididymis, and any gross lesions.
Exposure system
Five direct-flow nose-only exposure systems (RCC, Gen-
eva, Switzerland) were used in the study: 3 for the LA
aerosol, 1 for the AM aerosol, and 1 for the air control.
The exposure systems consisted of modular 16-port tiers
and were each configured into 6- or 7-tier towers lo-
cated in separate 8 m3 chambers for exposure contain-
ment and personnel safety (Additional file 1: Figure S3).
HEPA-filtered and conditioned supply and exhaust fans
controlled air flow through the 8 m3 chambers, and the
exhaust from each chamber was HEPA-filtered. Animals
were placed in open nose-only exposure restraint tubes
(Battelle Memorial, Richland, WA) and attached to the
towers via tier ports. For the 13-week inhalation study,
airflow into the towers was maintained at 50 L/min (air
control) or 57 L/min (LA and AM exposures), and ex-
haled air and excess exposure airflow were delivered into
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the tower exhaust plenum. Each 8 m3 chamber was
maintained at an average of 20–22 °C and 48–52 % rela-
tive humidity, and each tower was kept at 22–26 °C and
5–9 % relative humidity, representing animal environ-
ment and inhaled atmosphere conditions, respectively.
Four rotating brush aerosol generators (models CR-3000
or CR-3020, CR Equipements SA, Tannay, Switzerland)
were used to gently loft and aerosolize the fiber test ma-
terial for the LA and AM atmospheres. Each generator
controlled movement of a piston gently packed with a
column of sample into a rotating brush, which swept
material off the top of the column into the HEPA-
filtered air stream. Generator brush and piston speeds
were adjusted to achieve required aerosol mass concen-
trations. Sample fibers were delivered past a Kr85 source
(10 mCi; Isotopes Products Inc., Valencia, CA) to reduce
particle charges.
Exposure characterization
To determine aerosol concentration stability during
exposures, a light scatter respirable aerosol monitor
(RAM; MIE Inc., Billerica, MA) sampled aerosol con-
tinuously from a port at the tower inlet. Mass concentra-
tions in each tower were measured daily using glass fiber
filters (Pall Life Sciences, Ann Arbor, MI) collected from
an exposure port and weighed on a microbalance (ATI
CAHN model C31, Boston, MA). Particle size distribu-
tions were determined weekly using a calibrated optical
particle sizing spectrometer (Aerodynamic Particle Sizer
Model 3321, TSI, Inc., St. Paul, MN) connected to a port
at the tower inlet, avoiding overload by dilution with
HEPA-filtered air as necessary. Fiber size distributions
were determined weekly on samples collected on
polycarbonate filters. These filters were adhered to
25 mm aluminum pin mounts with conductive lubricant
(Neolube No.20, Huron, IN) and gold-coated (210–
280 Å thickness) with a sputter coater (SPI-Module
model 12151, West Chester, PA). An SEM (JEOL model
JSM-840A, Tokyo, Japan) captured sample images from
the gold-coated filters, which were analyzed with Image-
Pro Plus (v5.0.1.11 for Windows/XP, Media Cybernetics
Inc., Bethesda, MD) to count the number of all struc-
tures with any dimension ≥0.2 μm and measurements of
associated L and D across 15 fields at 5000x magnifica-
tion. Sample mass and size distributions measured at
top, middle, and bottom ports of each tower prior to the
start of animal exposures showed the samples were uni-
formly distributed throughout the exposure towers.
Animals
Animal use protocols were approved by the Institutional
Animal Care and Use Committees of the U.S. EPA and
the Hamner Institutes for Health Sciences and followed
in accordance with the Guiding Principles in the Use of
Animals in Toxicology and all relevant Animal Welfare
Act regulations in effect at the start of this study. Male
F344 (CDF) rats (Charles River Laboratories, Raleigh,
NC) were housed a minimum of 10 days before the start
of the studies in an AAALAC-accredited, specific-
pathogen-free facility under standard conditions (20–
24 °C, 30–70 % relative humidity, 12/12 h light/dark
cycle). Rats were housed in individual wire mesh cages
in the 8 m3 chambers during the 10-day and 13-week
exposure periods and in solid bottom cages with bedding
in separate rooms after the exposure periods. At the be-
ginning of the 13-week inhalation exposure, rats were
10 weeks old and weighed 200 ± 15 g (mean ± SD). All
animals received Certified Rodent Diet NIH-07 pellets
(Zeigler Bros., Gardners, PA) and filtered water ad libi-
tum. Animal body weights were recorded every week
and health status was monitored daily.
Tissue fiber burden
Tissue fiber burdens were determined 1 day, 1, 3, and
18 months after the 13-week exposure period. Animals
were euthanized with intraperitoneal sodium pentobar-
bital (up to 200 mg/kg) and exsanguinated via the ab-
dominal aorta. The head was removed and the URT was
isolated and stored at -80 °C. Aqueous 2 % agarose (type
1-B; Sigma-Aldrich, St. Louis, MO) with 0.1 % SDS
(Sigma) heated to 45 °C was injected slowly into the
pleural cavity, then heated agarose without SDS was in-
stilled into the lungs via a tracheal cannula [66]. After
placement of the carcass on ice for 30 min, the trachea
and larynx, LRT, pleural tissue, and mediastinal lymph
nodes were removed and stored at -80 °C until analyzed.
Samples were weighed before and after 6 h of freeze-
drying (Freezone system, Labconco, Kansas City, MO)
and then again following overnight freeze-drying to
ensure complete dryness. Freeze-dried samples were
weighed before low-temperature plasma ashing (LTA-
504, LFE Corporation, Springfield, VA) and 24 h later,
then ashed up to 96 h to ensure stable weight and
complete ashing. Ashed samples were resuspended in
water and spotted on polycarbonate filters, processed,
and analyzed as described above for the aerosol samples
to obtain numbers of fibers and their associated dimen-
sions (L, D). EDS was conducted on a JEOL JSM6510LV
SEM equipped with an EDAX Genesis XM2 EDS
analyzer system on a minimum of five structures per
sample from rats 18 months post-exposure to AM or
LA to confirm fiber identity.
Complete blood cell and bronchoalveolar lavage fluid
(BALF) analyses
Animals were anesthetized and exsanguinated as de-
scribed for fiber burden analysis, and blood was col-
lected in ethylenediaminetetraacetate (EDTA)-coated
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tubes for complete blood cell analysis. Blood was ana-
lyzed for hemoglobin (Hgb), hematocrit (Hct), mean cor-
puscular (MC) volume, MC Hgb (MCH), MC Hgb
concentration (MCHC), and numbers of white blood
cells (WBC), red blood cells (RBC), lymphocytes, and
platelets using a hematology analyzer (AcT 10; Beckman
Coulter, Miami, FL). The left lobe was ligated and right
lung lobes were lavaged with 3 ml PBS 5 times, keeping
the first lavage separate. BALF was centrifuged at 200 x
g for 10 min, and combined cell pellets were resus-
pended in 1 ml F12 medium and counted using a ZM
Coulter Counter (Beckman Coulter, Brea, CA). BALF
cell slide preparations were stained with Diff-Quick
(Fisher Scientific, Kalamazoo, MI), and 300 cells per
sample were differentiated as macrophages, neutrophils,
or lymphocytes. The first lavage supernatant was ana-
lyzed for markers of lung injury, including protein con-
tent and LDH, ALP, and NAG activities, using standard
reagents and protocols (Thermo Scientific, Rockford, IL;
Carolina Liquid Chemistries, Brea, CA; Pointe Scientific,
Canton, MI; and Roche Diagnostics, Indianapolis, IN).
All assays were conducted on a Cobas Fara II (Roche
Diagnostics) or AU600 (Olympus America, Center
Valley, PA) clinical chemistry analyzer.
Histopathology
Necropsy procedures were conducted by pathology staff
from Experimental Pathology Laboratories, Inc. (EPL®,
Morrisville, NC) at The Hamner Institute for Health
Sciences (Research Triangle Park, NC). In rats selected
for BALF, right lung lobes were removed after fluid
collection, frozen in liquid nitrogen, and stored at -80 °C
for analysis of RNA or protein markers as described
below. The left lung lobe ligature was removed, and the
trachea and left lung lobe were instilled and fixed in situ
with 10 % neutral buffered formalin (NBF) at approxi-
mately 30 cm NBF pressure. Left lung, trachea, sternum
(including pleura), left testis and epididymis, and any po-
tential lesions observed on gross examination were fixed
with NBF for 48 h, rinsed, and stored in 70 % ethanol.
Two early deaths in the 18-month post-exposure arm
(one each in the low-dose and mid-dose LA groups)
were not evaluated on histopathology due to tissue
autolysis.
Fixed tissues were embedded in paraffin wax, sec-
tioned at approximately 5 μm, deparaffinized, and
stained with hematoxylin and eosin (H&E) at EPL.
Additional slides from the left lung, trachea, and
sternum were stained with Masson-Goldner trichrome
stain to evaluate collagen content (as an indicator of
interstitial or (sub) pleural fibrosis). H&E- and
trichrome-stained sections were evaluated via light
microscopy by an experienced board-certified patholo-
gist at EPL (GAW). Histopathologic examination used
standard criteria and nomenclature for neoplastic and
non-neoplastic lesions [40, 67, 68]. Select microscopic
findings were graded using a subjective grading scale
(1 = minimal, 2 = slight/mild, 3 = moderate, 4 = moder-
ately severe, 5 = severe). Mean severity grades were
calculated by dividing the sum of the severity grades
for a finding in a group by the number of animals ex-
amined. Findings from early death animals were in-
cluded with originally assigned groups when pathology
data were available. Gross findings at necropsy were
correlated with histological findings when possible.
Slides were imaged using an Infinity2 digital camera
(Lumenera, Ottawa, ON).
Terminal bronchiolar epithelial cell proliferation
One day after the 10-day exposure period, seven rats/
group were surgically implanted in the dorsal thoracic
region with micro-osmotic pumps (Model 2 ML1 7-day
pump; Alzet, Cupertino, CA) using aseptic procedures
under isoflurane anesthesia. The pumps were filled with
BrdU (5 mg/mL in PBS), which was administered at
10 μL/h for 3 days. BrdU is a thymidine analog that se-
lectively labels cells entering the S-phase of the cell
cycle. Four days after the exposure period, animals were
necropsied and the left lung lobe from each animal was
fixed in NBF, transferred to ethanol, and processed as
described above. Lung sections were stained for BrdU by
EPL using standard immunohistochemical procedures
which included a primary mouse monoclonal antibody
for BrdU diluted 1:50 (Clone B44, Becton Dickinson,
San Jose, CA), biotinylated horse anti-mouse (rat
absorbed) IgG secondary antibody diluted 1:200 as a
linking reagent (BA-2001, Vector Laboratories, Burlin-
game, CA), peroxidase-conjugated avidin as the label
(ABC Complex Vector Kit, Vector Laboratories), and
3,3′-diaminobenzidine as the chromogen (Vector Mouse
IgG Standard Kit). A section of duodenum was used as
an internal positive control on each slide. Negative and
positive control slides were run with each immunostain-
ing batch. BrdU LI was determined by counting approxi-
mately 400 TB epithelial cells per slide (mean ± SE, 462
± 20) across up to seven fields/section by an observer
blind to experimental groups. Labeling index was calcu-
lated as the percentage of positively labeled cells out of
the total cells counted. Bronchioles with clear evidence
of inflammation were not counted.
Apoptosis and inflammation markers
Total RNA was isolated from homogenized right cranial
lung lobes from rats in the 10-day exposure study using
silica membrane spin columns (RNeasy mini-kit, Qiagen,
Valencia, CA). Following addition of RNAse inhibitor,
RNA yield was determined spectrophotometrically
(NanoDrop 1000, Thermo Scientific, Wilmington, DE).
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Real-time quantitative reverse transcription PCR (RT-
qPCR) was performed in duplicate samples (25 ng total
RNA) using SuperScript III One-step RT-qPCR kits
(Invitrogen, Grand Island, NY), probe (TaqMan 5′-la-
beled 6-carboxyfluorescein amidite), and primers for rat
Nlrp3, Pycard, Casp1, Il1b, Il6, Il18, Tnfa, Ifng, Cxcl2,
and 18S rRNA as an internal control for each sample
(primers and probe from Applied Biosystems Inc., Foster
City, CA). RT-qPCR for each transcript was run separ-
ately on an ABI Prism 7900 HT sequence detection
system (Applied Biosystems Inc., Foster City, CA) under
the following conditions: 20 min at 53 °C (reverse
transcription), 2 min at 95 °C (inactivation of reverse
transcriptase), followed by 40 cycles of 45 s at 60 °C and
15 s at 95 °C. Data were analyzed using ABI sequence
detection software (version 2.2). For each PCR plate,
cycle threshold (Ct) was set to an order of magnitude
above background, and each sample target gene Ct was
normalized to control 18S Ct. Expression in each
exposure group was quantified as percent of the air
control group.
Akt pathway, MAPK/ERK cascade, and inflammatory
cytokines
Right cranial lung lobes from rats necropsied 1 day, 1,
and 3 months after the 13-week exposure were homoge-
nized in Tris lysis buffer containing phosphatase and
protease inhibitors and phenylmethylsulfonyl fluoride
(Meso Scale Discovery (MSD), Gaithersburg, MD), and
analyzed for total protein. Multi-Spot® 96-well plates
(MSD) pre-coated with rat-specific capture anti-
bodies to proteins in the Akt pathway or the
MAPK/ERK cascade (both in 4-spot formats) were
prepared with blocking solution (MSD), and samples
were added at equal protein levels to each well. Ac-
tivated (phosphorylated) components measured in
the Akt signaling pathway included pAkt, p70S6K,
pS6RP, and pGSK-3β. Components measured in the
MAPK/ERK cascade included pERK1/2, pMEK1/2,
and pSTAT3. Inflammatory and allergic cytokines in
lung samples and calibrated cytokine standards were
measured in a blocked Multi-Spot® 96-well 7-spot
plate (MSD) pre-coated with rat-specific capture
antibodies to IL-1β, IL-4, IL-5, IL-13, IFN-γ, TNF-α,
and CXCL1. Plate washing, addition of detection
antibodies, and electrochemilumiscence detection on
a Sector Imager 2400 (MSD) were performed accord-
ing to manufacturer’s instructions. Activities in Akt
and MAPK/ERK pathways were quantified in each
exposure group as percent of the air control group.
Inflammatory and allergic cytokine levels were
expressed relative to total protein in the lung hom-
ogenate (pg/mg protein).
Statistical analysis
Statistical analyses were performed using Prism 6
(GraphPad Software), STATISTIX for Windows v2.0
(Analytical Software, Tallahassee, FL), JMP v8.0 (Cary,
NC), and SAS statistical package v9.4 (SAS Institute,
Cary, NC). Variance of continuous data was tested using
Levene’s test, Welch’s ANOVA, or a standard ANOVA.
Subsequent pairwise comparisons were made using a
Tukey-Kramer’s Honestly Significant Difference post hoc
test unless otherwise indicated. Cell proliferation data
(BrdU LI) were screened for distribution and homogen-
eity of variance and analyzed using ANOVA followed by
pairwise tests of least square means between control and
fiber-exposed groups. Pairwise P values were adjusted
using a Bonferroni multiple-comparison correction. A
linear test for trend was also applied to BrdU LI values
among LA dose groups. For histopathology data, a one-
sided Fisher’s exact test was used to evaluate group dif-
ferences in lesion incidence, and a Bonferroni correction
was applied to all pairwise P values. A dose response
trend for LA exposure was evaluated using a Cochran-
Armitage trend test on lung tumor and hyperplasia inci-
dence at 18 months post-exposure. For tumors, pairwise
and trend tests were run using all animals with path-
ology data (n = 49–50/group) and using a time-adjusted
reduced analysis in which early deaths that occurred
prior to the time at which the first lung tumor was ob-
served were excluded (n = 41–44/group) [69]. Group dif-
ferences or trend tests with an adjusted P value < 0.05
were considered statistically significant.
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